JKJin Hwan Kim

Jin Hwan Kim

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jin Hwan Kim has a total of 216 co-authors. Here are the top co-authors by number of shared publications:

  • Song Soo Kim

    Department of Radiology, Chungnam National University Hospital, Chungnam National University School of Medicine, Daejeon, Korea

    7 shared publications
  • Kyongtae T. Bae

    Mallinckrodt Institute of Radiology, Washington University School of Medicine, 510 S Kingshighway Blvd., St. Louis, MO 63110

    4 shared publications
  • Yeon Joo Jeong

    Department of Radiology, Pusan National University Hospital and Biomedical Research Institute, Pusan National University School of Medicine, Busan, Korea

    4 shared publications
  • Eun Young Kim

    Department of Neurosurgery, Gachon University Gil Medical Center, Gachon University College of Medicine, 24, Namdong-Daero 774Beon-Gil, Namdong-Gu, Incheon, Republic of Korea

    3 shared publications
  • Hyeyoung Kwon

    Department of Radiology, Chungnam National University Hospital, Chungnam National University School of Medicine, Daejeon, Korea

    3 shared publications
  • Hyun Ju Lee

    Department of Radiology, Seoul National University Hospital, Seoul, Korea

    3 shared publications

Latest Publications

  • Open Access

    The Journey of the Medicolegal Affairs Committee of the Korean Society of Radiology and a Vision for Its Future: Towards Sustainable Progress Beyond Eighty Years

    by Jin Hwan Kim

    김진환, et al. J Korean Soc Radiol. 2025 Nov;86(6):890-896. https://doi.org/10.3348/jksr.2025.0101


  • Open Access

    Artificial Intelligence-Driven Drafting of Chest X-Ray Reports: 2025 Position Statement From the Korean Society of Thoracic Radiology Based on an Expert Survey

    by Won Gi Jeong, Eui Jin Hwang, Gong Yong Jin, Ju-Hyung Lee, Se Ri Kang, Hongseok Ko, Bomi Gil, Jin Hwan Kim, Tae Jung Kim, Chan Ho Park, et al.

    Jeong WG, et al. Korean J Radiol. 2025 Sep;26:e75. https://doi.org/10.3348/kjr.2025.0457


  • Open Access

    Development and Validation of a Robust and Interpretable Early Triaging Support System for Patients Hospitalized With COVID-19: Predictive Algorithm Modeling and Interpretation Study

    by Sangwon Baek, Yeon Joo Jeong, Yun-Hyeon Kim, Jin Young Kim, Jin Hwan Kim, Eun Young Kim, Jae-Kwang Lim, Jungok Kim, Zero Kim, Kyunga Kim, et al.

    Background: Robust and accurate prediction of severity for patients with COVID-19 is crucial for patient triaging decisions. Many proposed models were prone to either high bias risk or low-to-moderate discrimination. Some also suffered from a lack of clinical interpretability and were developed based on early pandemic period data. Hence, there has been a compelling need for advancements in prediction models for better clinical applicability. Objective: The primary objective of this study was to develop and validate a machine learning–based Robust and Interpretable Early Triaging Support (RIETS) system that predicts severity progression (involving any of the following events: intensive care unit admission, in-hospital death, mechanical ventilation required, or extracorporeal membrane oxygenation required) within 15 days upon hospitalization based on routinely available clinical and laboratory biomarkers. Methods: We included data from 5945 hospitalized patients with COVID-19 from 19 hospitals in South Korea collected between January 2020 and August 2022. For model development and external validation, the whole data set was partitioned into 2 independent cohorts by stratified random cluster sampling according to hospital type (general and tertiary care) and geographical location (metropolitan and nonmetropolitan). Machine learning models were trained and internally validated through a cross-validation technique on the development cohort. They were externally validated using a bootstrapped sampling technique on the external validation cohort. The best-performing model was selected primarily based on the area under the receiver operating characteristic curve (AUROC), and its robustness was evaluated using bias risk assessment. For model interpretability, we used Shapley and patient clustering methods. Results: Our final model, RIETS, was developed based on a deep neural network of 11 clinical and laboratory biomarkers that are readily available within the first day of hospitalization. The features predictive of severity included lactate dehydrogenase, age, absolute lymphocyte count, dyspnea, respiratory rate, diabetes mellitus, c-reactive protein, absolute neutrophil count, platelet count, white blood cell count, and saturation of peripheral oxygen. RIETS demonstrated excellent discrimination (AUROC=0.937; 95% CI 0.935-0.938) with high calibration (integrated calibration index=0.041), satisfied all the criteria of low bias risk in a risk assessment tool, and provided detailed interpretations of model parameters and patient clusters. In addition, RIETS showed potential for transportability across variant periods with its sustainable prediction on Omicron cases (AUROC=0.903, 95% CI 0.897-0.910). Conclusions: RIETS was developed and validated to assist early triaging by promptly predicting the severity of hospitalized patients with COVID-19. Its high performance with low bias risk ensures considerably reliable prediction. The use of a nationwide multicenter cohort in the model development and validation implicates generalizability. The use of routinely collected features may enable wide adaptability. Interpretations of model parameters and patients can promote clinical applicability. Together, we anticipate that RIETS will facilitate the patient triaging workflow and efficient resource allocation when incorporated into a routine clinical practice.


  • Open Access

    Angioinvasive Mucormycosis Mimicking Mass and Pulmonary Thromboembolism in a Patient with Myelodysplastic Syndrome: A Case Report

    by Hyo Ju Na, Song Soo Kim, Shinhye Cheon, Jin Hwan Kim, Hyeyoung Kwon

    나효주, et al. J Korean Soc Radiol. 2023 Dec;85:e1. https://doi.org/10.3348/jksr.2023.0016


  • Open Access

    Development and Validation of a Robust and Interpretable Early Triaging Support System for Patients Hospitalized With COVID-19: Predictive Algorithm Modeling and Interpretation Study (Preprint)

    by Sangwon Baek, Yeon Joo Jeong, Yun-Hyeon Kim, Jin Young Kim, Jin Hwan Kim, Eun Young Kim, Jae-Kwang Lim, Jungok Kim, Zero Kim, Kyunga Kim, et al.

    Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Robust and accurate prediction of severity for patients with COVID-19 is crucial for patient triaging decisions. Many proposed models were prone to either high bias risk or low-to-moderate discrimination. Some also suffered from a lack of clinical interpretability and were developed based on early pandemic period data. Hence, there has been a compelling need for advancements in prediction models for better clinical applicability. Objective: The primary objective of this study was to develop and validate a machine learning–based Robust and Interpretable Early Triaging Support (RIETS) system that predicts severity progression (involving any of the following events: intensive care unit admission, in-hospital death, mechanical ventilation required, or extracorporeal membrane oxygenation required) within 15 days upon hospitalization based on routinely available clinical and laboratory biomarkers. Methods: We included data from 5945 hospitalized patients with COVID-19 from 19 hospitals in South Korea collected between January 2020 and August 2022. For model development and external validation, the whole data set was partitioned into 2 independent cohorts by stratified random cluster sampling according to hospital type (general and tertiary care) and geographical location (metropolitan and nonmetropolitan). Machine learning models were trained and internally validated through a cross-validation technique on the development cohort. They were externally validated using a bootstrapped sampling technique on the external validation cohort. The best-performing model was selected primarily based on the area under the receiver operating characteristic curve (AUROC), and its robustness was evaluated using bias risk assessment. For model interpretability, we used Shapley and patient clustering methods. Results: Our final model, RIETS, was developed based on a deep neural network of 11 clinical and laboratory biomarkers that are readily available within the first day of hospitalization. The features predictive of severity included lactate dehydrogenase, age, absolute lymphocyte count, dyspnea, respiratory rate, diabetes mellitus, c-reactive protein, absolute neutrophil count, platelet count, white blood cell count, and saturation of peripheral oxygen. RIETS demonstrated excellent discrimination (AUROC=0.937; 95% CI 0.935-0.938) with high calibration (integrated calibration index=0.041), satisfied all the criteria of low bias risk in a risk assessment tool, and provided detailed interpretations of model parameters and patient clusters. In addition, RIETS showed potential for transportability across variant periods with its sustainable prediction on Omicron cases (AUROC=0.903, 95% CI 0.897-0.910). Conclusions: RIETS was developed and validated to assist early triaging by promptly predicting the severity of hospitalized patients with COVID-19. Its high performance with low bias risk ensures considerably reliable prediction. The use of a nationwide multicenter cohort in the model development and validation implicates generalizability. The use of routinely collected features may enable wide adaptability. Interpretations of model parameters and patients can promote clinical applicability. Together, we anticipate that RIETS will facilitate the patient triaging workflow and efficient resource allocation when incorporated into a routine clinical practice.

  • Open Access

    Primary Malignant Peripheral Nerve Sheath Tumor of the Pulmonary Vein: A Case Report

    by Hyun Woo, Hyeyoung Kwon, Jin Hwan Kim, Song Soo Kim, Hyung Kyu Park, Younju Rhee, Jae-Hyeong Park

    심장과 대혈관 기원의 원발성 종괴는 매우 드물다. 그중에서도 악성 말초신경초종은 더 드물게 보고되었다. 76세 남성에서 발견된 흉수의 원인 평가를 위해 시행한 조영증강 컴퓨터단층 촬영에서 우폐정맥과 좌심방을 침범하는 저음영의 종괴가 발견되었고 초음파상 우폐정맥에서 기인한 종괴로 의심되었다. 종괴는 수술적 절제를 통해 폐정맥 기원의 악성 말초신경초종으로 최종 진단되었다. 저자들은 국내에서 보고된 바가 없는 드문 증례인 폐정맥 기원의 원발성 악성 말초신경초종을 보고하고, 종괴가 폐정맥 기원임을 시사하는 영상의학적 소견에 대해 고찰하고자 한다. Primary masses rarely originate from the heart and great vessels, and a malignant peripheral nerve sheath tumor (MPNST) is extremely rare. A 76-year-old male with pleural effusion underwent contrast-enhanced computed tomography, which revealed a hypoattenuating mass involving the right pulmonary vein and left atrium. Ultrasonography showed that the mass originated from the right pulmonary vein. Surgical resection confirmed an MPNST that originated from the pulmonary vein. We report the first Korean case of a primary MPNST originating from the pulmonary vein. We have also described the radiologic findings suggestive of a pulmonary vein mass.

  • Open Access

    Insidious Onset Multifocal Chest Wall and Spinal Abscess Caused by Previous Candidemia: A Case Report

    by Da Eun Kwon, Song Soo Kim, Shinhye Cheon, Jin Hwan Kim, Hyeyoung Kwon

    권다은, et al. J Korean Soc Radiol. 2023 Sep;84:e90. https://doi.org/10.3348/jksr.2022.0138

  • Open Access

    Development and Validation of a Multimodal-Based Prognosis and Intervention Prediction Model for COVID-19 Patients in a Multicenter Cohort

    by Jeong Hoon Lee, Jong Seok Ahn, Myung Jin Chung, Yeon Joo Jeong, Jin Hwan Kim, Jae Kwang Lim, Jin Young Kim, Young Jae Kim, Jong Eun Lee, Eun Young Kim

    The ability to accurately predict the prognosis and intervention requirements for treating highly infectious diseases, such as COVID-19, can greatly support the effective management of patients, especially in resource-limited settings. The aim of the study is to develop and validate a multimodal artificial intelligence (AI) system using clinical findings, laboratory data and AI-interpreted features of chest X-rays (CXRs), and to predict the prognosis and the required interventions for patients diagnosed with COVID-19, using multi-center data. In total, 2282 real-time reverse transcriptase polymerase chain reaction-confirmed COVID-19 patients’ initial clinical findings, laboratory data and CXRs were retrospectively collected from 13 medical centers in South Korea, between January 2020 and June 2021. The prognostic outcomes collected included intensive care unit (ICU) admission and in-hospital mortality. Intervention outcomes included the use of oxygen (O2) supplementation, mechanical ventilation and extracorporeal membrane oxygenation (ECMO). A deep learning algorithm detecting 10 common CXR abnormalities (DLAD-10) was used to infer the initial CXR taken. A random forest model with a quantile classifier was used to predict the prognostic and intervention outcomes, using multimodal data. The area under the receiver operating curve (AUROC) values for the single-modal model, using clinical findings, laboratory data and the outputs from DLAD-10, were 0.742 (95% confidence interval [CI], 0.696–0.788), 0.794 (0.745–0.843) and 0.770 (0.724–0.815), respectively. The AUROC of the combined model, using clinical findings, laboratory data and DLAD-10 outputs, was significantly higher at 0.854 (0.820–0.889) than that of all other models (p < 0.001, using DeLong’s test). In the order of importance, age, dyspnea, consolidation and fever were significant clinical variables for prediction. The most predictive DLAD-10 output was consolidation. We have shown that a multimodal AI model can improve the performance of predicting both the prognosis and intervention in COVID-19 patients, and this could assist in effective treatment and subsequent resource management. Further, image feature extraction using an established AI engine with well-defined clinical outputs, and combining them with different modes of clinical data, could be a useful way of creating an understandable multimodal prediction model.


  • Open Access

    Difficulties in Differentiating Cardiac Lymphoma and Metastasis Based on Radiologic Features: Two Case Reports

    by Hyun Jae Lim, Song Soo Kim, Kye Taek Ahn, Kun Ho Kim, Jin Hwan Kim

    Cardiac tumors are rare diseases with various imaging findings. However, differentiating cardiac tumors based on imaging findings is challenging because of similarities in imaging features. We present two cases of cardiac tumors, including primary cardiac lymphoma and cardiac metastasis, in which the differential diagnosis was difficult.


  • Open Access

    Ectopic Mediastinal Parathyroid Adenoma in a Patient with Chronic Kidney Disease: A Case Report

    by Dong Min Choo, Jin Hwan Kim, Song Soo Kim

    Choo DM, et al. J Korean Soc Radiol. 2019 Jan;80(1):147-152. https://doi.org/10.3348/jksr.2019.80.1.147